VIM
EW icon

Vancity Investment Management’s Edwards Lifesciences EW Stock Holding History

Vancity Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Buy
167,876
+22,881
+16% +$1.92M 2.28% 15
2026
Q1 		$11.6M Buy
144,995
+33,333
+30% +$2.75M 1.84% 24
2025
Q4 		$9.52M Sell
111,662
-6,371
-5% -$523K 1.29% 26
2025
Q3 		$9.18M Sell
118,033
-5,460
-4% -$427K 1.22% 29
2025
Q2 		$9.66M Sell
123,493
-5,736
-4% -$428K 1.22% 27
2025
Q1 		$9.37M Buy
+129,229
New +$9.25M 1.28% 26
2024
Q3 		$9.22M Sell
139,763
-138,869
-50% -$10.1M 1.11% 29
2024
Q2 		$24.2M Buy
278,632
+136,511
+96% +$12.1M 1.53% 26
2024
Q1 		$13.6M Buy
142,121
+104,047
+273% +$8.74M 1.62% 23
2023
Q4 		$2.9M Sell
38,074
-68,527
-64% -$4.77M 0.43% 42
2023
Q3 		$7.38M Buy
+106,601
New +$8.57M 0.96% 39

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Vancity Investment Management's EW Position: Q2 2026 in Review

Vancity Investment Management increased its Edwards Lifesciences (EW) stake by 16% in Q2 2026, buying an estimated $1.92M and bringing the position to 167,876 shares worth $15.2M. The position accounts for 2.28% of the portfolio, ranked #15.

Vancity Investment Management first reported a position in EW in Q3 2023 and has held it in 11 quarters since. The position peaked at $24.2M in Q2 2024. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Vancity Investment Management held 167,876 shares of Edwards Lifesciences worth $15.2M as of Q2 2026.
  • Vancity Investment Management bought 22,881 Edwards Lifesciences shares in Q2 2026, an estimated $1.92M.
  • Edwards Lifesciences made up 2.28% of Vancity Investment Management's portfolio in Q2 2026, its #15 holding.
  • Vancity Investment Management first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 11 quarters since.
  • Vancity Investment Management's Edwards Lifesciences position peaked at $24.2M in Q2 2024.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Vancity Investment Management's 13F filing for Q2 2026, filed 24 Aug 2026.